The company is paying China-based biotech LaNova Medicines $588 million for the kind of dual-pronged antibody drug that ...

Merck KGaA reported a 16.6% decline in contract manufacturing due to an unrepeated Covid-19 contract, though overall life ...

After a research note raised potential safety concerns with Amgen's lead obesity candidate, the company defended its drug and ...

Merck & Co. has struck a licensing deal with LaNova Medicines that is potentially worth more than $3 billion to the clinical-stage biotechnology company.

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Diwali is upon us, which means skies are set to be filled with fireworks, and beautiful candles will be displayed in homes. Also known as Divali or Deepawali, Diwali is celebrated over five days ...

High-quality end of life care is important to ensure people approaching the end of life, and their family and carers, have access to appropriate treatment and support during a vulnerable and difficult ...

In this image of the sparkling Serpens Nebula, located 1,300 light-years away in the constellation Serpens, newborn stars roar to life ... cartwheel through the background. Like a celestial ...

Our Life Sciences Masters™ 2024 program will focus on the intersection of intellectual property and the biopharmaceutical industry. With topics covering the innovation ecosystem, the PTO ...

I had a science background, and there was a crime lab opening ... A job with a low stress level, good work-life balance and solid prospects to improve, get promoted and earn a higher salary ...

Switching from a science background to a business one is a journey ... which is what I wanted to do throughout my university life." Despite the increasing opportunities in business, it may not ...